Navigation Links
Biodel Reports Positive Top-Line Results from Study of Experimental Ultra-Rapid-Acting Insulin Formulations
Date:4/15/2012

a-rapid absorption profile of Linjeta™, while improving injection site toleration.  These recent data suggest that our latest formulations have achieved this goal, and we feel that further clinical development is warranted." 

Dr. Errol De Souza, Biodel's president and chief executive officer, stated: "The findings from these studies are very encouraging and will enable us to advance an ultra-rapid-acting RHI-based formulation into a Phase 2 clinical trial as early as next quarter.  In parallel, we will continue our development of ultra-rapid-acting insulin analog-based formulations, with the goal of advancing product candidates into a Phase 1 clinical trial later in 2012.  We expect our ultra-rapid-acting insulin program, along with our liquid glucagon rescue program that is targeted for NDA filing by the end of 2013 or early 2014, to generate multiple meaningful milestones in the short-term." 

Phase 1 Study in Patients with Type 1 Diabetes (n=12)Pharmacokinetic Profiles of BIOD-123, BIOD-125 and Humalog® Treatment

MetricsEarly 1/2 Tmax

(minutes)

Tmax

(minutes)

Late 1/2 Tmax

(minutes)Humalog®

27.0 +/- 2.7

(25.9)

65.0 +/- 7.0

(67.5)

151 +/- 11

(150)BIOD-123

9.8 +/- 1.1*

(9.6)

46.4 +/- 14.9

(25.0)

206 +/- 35

(170)BIOD-125

12.4 +/- 2.0*

(9.4)

60.8 +/- 15.2

(30.0)

179 +/- 41

(140)-- Data represent the Mean +/- SEM; Median Values are presented in parentheses. 

* p<0.001 vs. Humalog® Injection Site Toleration Profiles of BIOD-123, BIOD-125 and Humalog®Treatment

MetricsTolerability

(VAS 0 – 100mm)

Absolute Severity

Score

Relative Severity ScoreHumalog®

1.8  +/- 1.1

0.17 +/-  0.11

2.92 +/-  0.08 BIOD-123
'/>"/>

SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report
2. Biodel to Provide Update on Stabilized Glucagon Program at ROTH Conference Today
3. Federal Court Grants Request by BioDelivery Sciences for Stay of MonoSol Litigation
4. Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012
5. US Patent Office Rejection of All Claims in Final Asserted MonoSol Patent Further Supports BioDelivery Sciences Position
6. BioDelivery Sciences and FDA Reach Agreement on BNX Development Plan
7. Biodel Inc. to Present at 30th Annual JPMorgan Healthcare Conference on January 12th, 2012
8. Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine
9. BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
10. BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study
11. Biodel to Report Fourth Quarter Fiscal Year 2011 Financial Results on December 6, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... EAST RUTHERFORD, N.J., May 1, 2015 Cambrex Corporation ... ended March 31, 2015. Highlights ... 2014, and increased 27% excluding foreign currency impact, driven by ... $18.0 million from $8.4 million in the first quarter of ... $0.26 versus $0.04 in the first quarter last year and ...
(Date:4/30/2015)... , April 30, 2015 /PRNewswire/ - Pivotal ... pharmaceutical company with a focus on Omega-3 therapies ... its operational highlights and financial results for the ... amounts referenced herein are in Canadian dollars unless ... have been significant, with the right strategic partners ...
(Date:4/30/2015)... 2015 Omnicell, Inc. (NASDAQ: OMCL ), a ... healthcare systems, today announced results for its first quarter ... for the first quarter of 2015 was $116.2 million, ... of 2014, and down $5.3 million or 4.4% from ... 2015 net income as reported in accordance with U.S. ...
Breaking Medicine Technology:Cambrex Reports First Quarter 2015 Financial Results 2Cambrex Reports First Quarter 2015 Financial Results 3Cambrex Reports First Quarter 2015 Financial Results 4Cambrex Reports First Quarter 2015 Financial Results 5Cambrex Reports First Quarter 2015 Financial Results 6Cambrex Reports First Quarter 2015 Financial Results 7Cambrex Reports First Quarter 2015 Financial Results 8Cambrex Reports First Quarter 2015 Financial Results 9Cambrex Reports First Quarter 2015 Financial Results 10Cambrex Reports First Quarter 2015 Financial Results 11Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21
... Managing multiple brands for the same indication is a ... product can translate into expanded market share and improved ... new product gaining market share at the expense of ... of identifying successful strategies and tactics for marketing multiple ...
... Dec. 10, 2010 Tomophase Corporation, developer of ... and other devices, announced today that it has ... Tomophase is a leader in the development ... OCTIS is comprised of a single-use disposable optical ...
Cached Medicine Technology:Maximizing the Potential of Multi-Drug Portfolios Without Cannibalizing from a Legacy Brand 2Tomophase OCTIS(TM) Receives FDA 510(K) Clearance to Market 2
(Date:5/2/2015)... (PRWEB) May 02, 2015 With the success ... company is proud to welcome Neida Miranda and Alex Shields ... Dental Consulting has over 41 years of combined experience working ... been in the dental field for 8 years. She ... in Waco, Texas. Customer service, positive attitude and showing the ...
(Date:5/1/2015)... Jusuru International has been awarded the prestigious 2015 ... flagship nutritional supplement, Liquid BioCell™ Life, and the relaunch ... logo, new packaging, new products, and new messaging. ... and promote programs that serve as examples of direct ... International for their outstanding accomplishments and contributions to direct ...
(Date:5/1/2015)... Washington, DC (PRWEB) May 01, 2015 It’s ... Senate and House introducing proposals to expand federal support for ... 22 years that ATA has been working with Congress,” said ... “These actions signify how the nation is poised to embrace ... This is one more step in fulfilling ATA’s mission to ...
(Date:5/1/2015)... Florida (PRWEB) May 01, 2015 The Quail ... the American Cancer Society. Since 2001, the Quail Creek Relay ... Relay team host events throughout the year, including their biggest ... the Golf Ball Drop. , Quail Creek Relay for ... was battling cancer. Kate Kerwin, fitness director, states, “I was ...
(Date:5/1/2015)... The frozen yogurt chain sweetFrog Enterprises is ... and the Myrtle Beach Pellicans (SC). As part of ... offer fans discounts at local sweetFrog locations. , “We ... Luke Shook, co-owner of the Hickory sweetFrog. “Sponsoring ... forward to enjoying the games and the great taste ...
Breaking Medicine News(10 mins):Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2Health News:sweetFrog Announces Minor League Baseball Partnerships 2
... , ST. LOUIS, Nov. 20 ... that it will present at the Bank of America Merrill ... at the Crowne Plaza Hotel Times Square in New York ... a.m. Eastern Time. Investors and other interested parties may access ...
... Journal of the National Cancer Institute discusses the ... of cancer research. The editorial provides guidance for both the ... M. Schwartz, M.D., M.S., and Steven Woloshin, M.D., M.S., of ... for Health Policy and Clinical Practice in New Hampshire, and ...
... short as 34 weeks, potentially adding to preemie delivery rate, experts ... that the rate of preterm deliveries continues to climb in the ... Many women are confused about what constitutes a full-term birth in ... the study considered a baby born at 34 to 36 weeks ...
... , , Project Bread ... , BOSTON, Nov. 20 Project Bread, the state,s ... report on hunger in the Commonwealth. The disquieting trends described ... people in the Commonwealth struggling with hunger. Food insecurity has ...
... Today, iconic denim brand DKNY JEANS and multi-channel ... offered exclusively on HSN and HSN.com for the holiday season. ... Research Hospital,s Thanks and Giving® Program, a holiday fundraising ... healthy kids in your lives and to give to those who ...
... Nov. 20 Fear about the risk of surgery is ... aortic valve replacement surgery, according to a study by physicians ... this year, former First Lady Barbara Bush and comedian Robin ... be missing out on the potentially life-saving surgery. , In ...
Cached Medicine News:Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:554,000 in Massachusetts Struggle to Put Food on the Table 2Health News:554,000 in Massachusetts Struggle to Put Food on the Table 3Health News:554,000 in Massachusetts Struggle to Put Food on the Table 4Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 3Health News:Half of Eligible Patients Do Not Get Aortic Valve Replacement 2
... solution tricompartmental total knee prosthesis stems from ... State-of-the-art design and manufacturing technologies have been ... function as well as a favorable pressure ... to keep wear to a minimum. The ...
... was designed for patients with difficult problems ... custom designs to repair difficult anatomic conditions. ... which reduces the chance of dislocation in ... been streamlined and updated so that the ...
The design and concept of the Alpina knee allows the choice of implanting a PCL retaining or a posterior stabilized prosthesis intraoperatively....
... knee prosthesis stems from many years of ... manufacturing technologies have been used in order ... as a favorable pressure distribution pattern on ... to a minimum. The inherent design of ...
Medicine Products: